Stromal Cell-Derived Factor-1 Alpha Is Decreased in Women With Migraine With Aura

被引:8
|
作者
Liman, Thomas G. [1 ,2 ,3 ]
Neeb, Lars [1 ,3 ]
Rosinski, Jana [1 ]
Reuter, Uwe [3 ]
Endres, Matthias [1 ,3 ,4 ,5 ,6 ,7 ]
机构
[1] Charite, Ctr Stroke Res Berlin, Berlin, Germany
[2] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA
[3] Charite, Dept Neurol, Berlin, Germany
[4] Charite, German Ctr Neurodegenerat Dis DZNE, Berlin, Germany
[5] Charite, Excellence Cluster Neurocure, Berlin, Germany
[6] German Ctr Cardiovasc Res DZHK, Berlin, Germany
[7] Berlin Inst Hlth BIH, Berlin, Germany
来源
HEADACHE | 2016年 / 56卷 / 08期
关键词
stromal cell-derived factor-1 alpha; migraine; endothelial dysfunction; stroke risk; ENDOTHELIAL PROGENITOR CELLS; ARTERIAL ELASTICITY; VIVO; NEOVASCULARIZATION; FACTOR-1-ALPHA; RECRUITMENT; DYSFUNCTION; STIFFNESS;
D O I
10.1111/head.12839
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background.-Endothelial dysfunction may contribute to the pathophysiology of migraine with aura. Stromal cell-derived factor-1 alpha (SDF-1 alpha) is involved in the maintenance of endothelial integrity via mobilization of vascular stem cells. Objectives.-We sought to determine whether SDF-1 alpha levels are decreased in women with MA. Methods.-In this post hoc analysis of a case-cohort study, levels of SDF-1 alpha were determined by enzyme-linked immunosorbent assay. Endothelial function was assessed using peripheral arterial tonometry. Arterial stiffness was assessed by fingertip tonometry derived and heart-rate-adjusted augmentation index (AI). Results.-Twenty-eight women with MA and 27 age-matched healthy women were included in this study. Levels of SDF-1 alpha were significantly lower in women with MA compared to age-and risk factor-matched healthy women (17636281 vs 2013 +/- 263 pg/mL, P = 0.006). SDF-1 alpha levels were positively correlated with AI in healthy women (r = 0.49, P = 0.009), but not in women with MA (r=0.05, P=0.78). SDF-1 alpha levels were negatively correlated with CD144-positive endothelial microparticles (EMP; r = 20.31, P = .02), and activated CD62E-positive EMP (r = -0.35, P = .01). Conclusion.-Levels of SDF-1 alpha are decreased in women with MA and are associated with EMPs as a surrogate marker of endothelial dysfunction. This might contribute to the pathophysiology and vascular risk in MA, but evidence from larger prospective studies is warranted.
引用
收藏
页码:1274 / 1279
页数:6
相关论文
共 50 条
  • [21] Stromal cell-derived factor-1 alpha alleviates hypoxic-ischemic brain damage in mice
    Yu, Qin
    Zhou, Liping
    Liu, Lizhen
    Cong, Li
    Wang, Yan
    Ge, Tingting
    Lin, Deju
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 464 (02) : 447 - 452
  • [22] Stromal cell-derived factor-1α confers protection against myocardial ischemia/reperfusion injury -: Role of the cardiac stromal cell-derived factor-1α-CXCR4 axis
    Hu, Xiaofeng
    Dai, Shujing
    Wu, Wen-Jian
    Tan, Wei
    Zhu, Xiaoping
    Mu, Jingyao
    Guo, Yiru
    Bolli, Roberto
    Rokosh, Gregg
    CIRCULATION, 2007, 116 (06) : 654 - 663
  • [23] Stromal Cell-Derived Factor-1 Stimulates Cell Recruitment, Vascularization and Osteogenic Differentiation
    Eman, Rhandy M.
    Oner, F. Cumhur
    Kruyt, Moyo C.
    Dhert, Wouter J. A.
    Alblas, Jacqueline
    TISSUE ENGINEERING PART A, 2014, 20 (3-4) : 466 - 473
  • [24] Stromal cell-derived factor-1 mediates stem cell homing in ischemic cardiomyopathy
    Askari, AT
    Goldman, CK
    Forudi, F
    Kiedrowski, MJ
    Ellis, SG
    Dicorleto, PE
    Penn, MS
    CIRCULATION, 2002, 106 (19) : 178 - 178
  • [25] Stromal Cell-Derived Factor-1 Is Essential for Photoreceptor Cell Protection in Retinal Detachment
    Otsuka, Hiroki
    Arimura, Noboru
    Sonoda, Shozo
    Nakamura, Makoto
    Hashiguchi, Teruto
    Maruyama, Ikuro
    Nakao, Shintaro
    Hafezi-Moghadam, Ali
    Sakamoto, Taiji
    AMERICAN JOURNAL OF PATHOLOGY, 2010, 177 (05): : 2268 - 2277
  • [26] EXPRESSION OF STROMAL CELL-DERIVED FACTOR-1 IN ENDOMETRIOSIS AND ENDOMETRIOID OVARIAN CANCER
    Sobstyl, M.
    Wertel, I.
    Bobinski, M.
    Barczynski, B.
    Bednarek, W.
    Putowski, L.
    Tarkowski, R.
    Fraszczak, K.
    Ziober-Malinowska, P.
    Walankiewicz, M.
    Kotarski, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 255 - 255
  • [27] Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1
    Jo, DY
    Rafii, S
    Hamada, T
    Moore, MAS
    JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (01): : 101 - 111
  • [28] Identification of a Potential Modification Site in Human Stromal Cell-Derived Factor-1
    Baumann, Lars
    Beck-Sickinger, Annette G.
    BIOPOLYMERS, 2010, 94 (06) : 771 - 778
  • [29] Increase of circulating stromal cell-derived factor-1 in heart failure patients
    Liu, K.
    Yang, S.
    Hou, M.
    Chen, T.
    Liu, J.
    Yu, B.
    HERZ, 2015, 40 : 70 - 75
  • [30] Stromal cell-derived factor-1 antagonizes slit/robo signaling in vivo
    Chalasani, Sreekanth H.
    Sabol, Angela
    Xu, Hong
    Gyda, Michael A.
    Rasband, Kendall
    Granato, Michael
    Chien, Chi-Bin
    Raper, Jonathan A.
    JOURNAL OF NEUROSCIENCE, 2007, 27 (05): : 973 - 980